| |||||||||||||||||||
Type Mutant Stock; Targeted Mutation; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Species laboratory mouse Generation N6p+N1
Generation DefinitionsDonating Investigator Kevin Campbell, University of Iowa Description
Mice that are homozygous for this floxed allele are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities. When these mutant mice are bred to mice that express cre recombinase, resulting offspring can have exon 2 of the targeted gene deleted in the cre-expressing tissue(s). As the targeted gene has three loxP sites, other genotypes may also result. These mutant mice may be useful in studying muscle disease and regeneration.When bred to a strain expressing Cre recombinase under the control of the human glial fibrillary acidic protein promoter (GFAP) (see Stock No. 004600 for example), this mutant mouse strain may be useful in studies of brain abnormalities observed in congenital muscular dystrophies.
Development
A targeting vector was used to introduce a loxP site downstream of exon 2 and insert a floxed neo cassette in the upstream intron. The construct was electroporated into (129X1/SvJ x 129S1/Sv)F1-Kitl+-derived R1 embryonic stem (ES) cells. ES cells were injected into blastocysts. Chimeric animals were backcrossed to 129S1/SvImJ by the donating laboratory for six generations.
| Control | ||
|---|---|---|
| 002448 129S1/SvImJ | (approximate) | |
| Considerations for Choosing Controls | ||
Strains carrying Dag1tm2Kcam allele
006834 B6.129-Dag1tm2Kcam/J View Strains carrying Dag1tm2Kcam (1 strain)
Strains carrying other alleles of Dag1
009652 B6.129(Cg)-Dag1tm2.1Kcam/J 006836 B6.129-Dag1tm1Kcam/J View Strains carrying other alleles of Dag1 (2 strains)
Introduction to Cre-lox technology
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
The following phenotype relates to a compound genotype created using this strain.
Contact JAX® Services jaxservices@jax.org for customized breeding options.Dag1tm2Kcam/Dag1tm2Kcam Tg(GFAP-cre)25Mes/0
involves: 129S1/Sv * 129X1/SvJ * FVB/N (conditional)
- craniofacial phenotype
- megacephaly (MGI Ref ID J:86901)
- nervous system phenotype
- abnormal brain morphology (MGI Ref ID J:86901)
- fusion of the cerebral interhemispheric fissure and adjacent cerebellar folia
- malformations resembling polymicrogyria
- abnormal cerebellar cortex morphology (MGI Ref ID J:86901)
- cerebellar cortical surfaces show widespread discontinuities of the glia limitans (pial surface basal lamina) accompanied by glial neuronal heterotopia within the leptomeninges
- abnormal cerebellum development (MGI Ref ID J:86901)
- granule cells are observed in the subrarachnoid space during postnatal cerebellar development indicating aberrant migration of granule cells
- abnormal cerebral cortex morphology (MGI Ref ID J:86901)
- cerebral cortical surfaces show widespread discontinuities of the glia limitans (pial surface basal lamina) accompanied by glial neuronal heterotopia within the leptomeninges
- abnormal stratification in cerebral cortex (MGI Ref ID J:86901)
- multifocal disarray of neuronal layering in the cerebral cortex
- abnormal hippocampus CA1 region morphology (MGI Ref ID J:86901)
- some mutants show minor dispersion of neuronal cell bodies in the CA1 region
- abnormal hippocampus granule cell layer (MGI Ref ID J:86901)
- some mutants show focal irregularities of the dentate granule cell layer in the hippocampus
- increased brain size (MGI Ref ID J:86901)
- about 20% increase in brain size
- abnormal neuronal migration (MGI Ref ID J:86901)
- cerebral, cerebellar and brain stem neuronal migration abnormalities
- abnormal subarachnoid space morphology (MGI Ref ID J:86901)
- the normally open subarachnoid space is filled with heterotopic astrocytic and neuronal processes
- astrocytosis (MGI Ref ID J:86901)
- GFAP-immunoreactive astrocytes are prominent in the cerebral cortex, indicating gliosis
- reduced long term potentiation (MGI Ref ID J:86901)
- induction of long-term potentiation (LTP) by high-frequency stimulation is blunted in hippocampal slices, however baseline neurotransmission is unaffected and presynaptic neurotransmitter release is not affected
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
Research Tools
Cre-lox System
loxP-flanked Sequences
| Allele Symbol | Dag1tm2Kcam | ||
|---|---|---|---|
| Allele Name | targeted mutation 2, Kevin Campbell | ||
| Allele Type | Targeted (Floxed/Frt) | ||
| Common Name(s) | DG (lox); DG-flox; DGlox; Dag1L; Dag1flox; Dag1lox; | ||
| Mutation Made By | Kevin Campbell, University of Iowa | ||
| Strain of Origin | (129X1/SvJ x 129S1/Sv)F1-Kitl<+> | ||
| ES Cell Line Name | R1 | ||
| ES Cell Line Strain | (129X1/SvJ x 129S1/Sv)F1-Kitl<+> | ||
| Gene Symbol and Name | Dag1, dystroglycan 1 | ||
| Chromosome | 9 | ||
| Gene Common Name(s) | 156DAG; A3a; AGRNR; D9Wsu13e; DAG; DG; DNA segment, Chr 9, Wayne State University 13, expressed; alpha-dystroglycan; beta-dystroglycan; dystrophin associated glycoprotein 1; | ||
| General Note | Phenotypic Similarity to Human Syndrome: Type II (cobblestone) Lissencephaly (J:86901). | ||
| Molecular Note | Exon 2 was floxed by introducing a loxP site downstream of exon 2 and by inserting a floxed neo cassette into the upstream intron via homologous recombination. [MGI Ref ID J:78838] | ||
Genotyping Protocols
Dag1tm2Kcam, Standard PCR
Helpful Links
Genotyping resources and troubleshooting
Cohn RD; Henry MD; Michele DE; Barresi R; Saito F; Moore SA; Flanagan JD; Skwarchuk MW; Robbins ME; Mendell JR; Williamson RA; Campbell KP. 2002. Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell 110(5):639-48. [PubMed: 12230980] [MGI Ref ID J:78838]
Dag1tm2Kcam relatedBeedle AM; Nienaber PM; Campbell KP. 2007. Fukutin-related protein associates with the sarcolemmal dystrophin-glycoprotein complex. J Biol Chem 282(23):16713-7. [PubMed: 17452335] [MGI Ref ID J:122734]
Court FA; Hewitt JE; Davies K; Patton BL; Uncini A; Wrabetz L; Feltri ML. 2009. A laminin-2, dystroglycan, utrophin axis is required for compartmentalization and elongation of myelin segments. J Neurosci 29(12):3908-19. [PubMed: 19321787] [MGI Ref ID J:147273]
Han R; Kanagawa M; Yoshida-Moriguchi T; Rader EP; Ng RA; Michele DE; Muirhead DE; Kunz S; Moore SA; Iannaccone ST; Miyake K; McNeil PL; Mayer U; Oldstone MB; Faulkner JA; Campbell KP. 2009. Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan. Proc Natl Acad Sci U S A 106(31):12573-9. [PubMed: 19633189] [MGI Ref ID J:152005]
Jarad G; Miner JH. 2009. The Pax3-Cre transgene exhibits a rostrocaudal gradient of expression in the skeletal muscle lineage. Genesis 47(1):1-6. [PubMed: 18942111] [MGI Ref ID J:144640]
Levi S; Grady RM; Henry MD; Campbell KP; Sanes JR; Craig AM. 2002. Dystroglycan is selectively associated with inhibitory GABAergic synapses but is dispensable for their differentiation. J Neurosci 22(11):4274-85. [PubMed: 12040032] [MGI Ref ID J:125567]
Moore SA; Saito F; Chen J; Michele DE; Henry MD; Messing A; Cohn RD; Ross-Barta SE; Westra S; Williamson RA; Hoshi T; Campbell KP. 2002. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 418(6896):422-5. [PubMed: 12140559] [MGI Ref ID J:86901]
Nishimune H; Valdez G; Jarad G; Moulson CL; Muller U; Miner JH; Sanes JR. 2008. Laminins promote postsynaptic maturation by an autocrine mechanism at the neuromuscular junction. J Cell Biol 182(6):1201-15. [PubMed: 18794334] [MGI Ref ID J:142595]
Nodari A; Previtali SC; Dati G; Occhi S; Court FA; Colombelli C; Zambroni D; Dina G; Del Carro U; Campbell KP; Quattrini A; Wrabetz L; Feltri ML. 2008. Alpha6beta4 integrin and dystroglycan cooperate to stabilize the myelin sheath. J Neurosci 28(26):6714-9. [PubMed: 18579745] [MGI Ref ID J:137852]
Occhi S; Zambroni D; Del Carro U; Amadio S; Sirkowski EE; Scherer SS; Campbell KP; Moore SA; Chen ZL; Strickland S; Di Muzio A; Uncini A; Wrabetz L; Feltri ML. 2005. Both laminin and Schwann cell dystroglycan are necessary for proper clustering of sodium channels at nodes of ranvier. J Neurosci 25(41):9418-27. [PubMed: 16221851] [MGI Ref ID J:101621]
Saito F; Moore SA; Barresi R; Henry MD; Messing A; Ross-Barta SE; Cohn RD; Williamson RA; Sluka KA; Sherman DL; Brophy PJ; Schmelzer JD; Low PA; Wrabetz L; Feltri ML; Campbell KP. 2003. Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron 38(5):747-58. [PubMed: 12797959] [MGI Ref ID J:83782]
Weir ML; Oppizzi ML; Henry MD; Onishi A; Campbell KP; Bissell MJ; Muschler JL. 2006. Dystroglycan loss disrupts polarity and {beta}-casein induction in mammary epithelial cells by perturbing laminin anchoring. J Cell Sci 119(Pt 19):4047-58. [PubMed: 16968749] [MGI Ref ID J:113187]
Colony Maintenance
Breeding & Husbandry When maintaining a live colony, homozygous mice may be bred.
| Pricing for USA, Canada and Mexico shipping destinations |
|
|
Animals Provided
Price (US dollars $) Cryorecovery Fee $1900.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
| Pricing for International shipping destinations |
|
|
Animals Provided
Price (US dollars $) Cryorecovery Fee $2470.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
| Standard Supply | Cryopreserved. Ready for recovery. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| 002448 129S1/SvImJ | (approximate) | |
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 1-800-422-6423 or 1-207-288-5845
Fax: 1-207-288-6150
Technical Support Email Form
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. In purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.